Here’s what you need to know:
1. Patients of NueHealth’s provider networks will have access to three screening types, including ColonSentry, a screening test that provides early risk stratification for colorectal cancer.
2. ColonSentry utilizes a blood test, which measures the expression of gene biomarkers that are early warning signs of colorectal cancer.
3. The tests will be processed by GeneNews at a clinical reference lab in Richmond, Va.
More articles on gastroenterology and endoscopy:
Vitamin A metabolite may suppress colorectal cancer: 5 study insights
Hannibal Regional Medical Group adds Dr. Ashraf Almashhrawi: 5 things to know
Migraines associated with GI disorders: 5 study insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.